Lipid materials for topical and transdermal delivery of nanoemulsions

Critical Reviews in Therapeutic Drug Carrier Systems

Volumn 31, Issue 5, 2014, Pages 429-458

  Pawar, Kasturi R ^a   Babu, R Jayachandra ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Fatty acid esters; Fatty acids; Fatty alcohols; Medium chain glycerides; Microemulsion; Nanoemulsion; Vegetable oils

Indexed keywords

EMULSION; LIPID; NANOMATERIAL;

ADMINISTRATION AND DOSAGE; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; EMULSION; HUMAN; INTRADERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; DRUG DELIVERY SYSTEMS; EMULSIONS; HUMANS; LIPIDS; NANOSTRUCTURES;

EID: 84906732837     PISSN: 07434863     EISSN: 2162660X     Source Type: Journal    
DOI: 10.1615/CritRevTherDrugCarrierSyst.2014010663     Document Type: Article

References (176)

1. Barry B. Breaching the skin's barrier to drugs. Nat Biotechnol. 2004; 22(2): 165-7.
2. Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL. Challenges and opportunities in dermal/transdermal delivery. Ther Deliv. 2010; 1(1): 109-31.
3. Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008; 26(11): 1261-8.
4. Morrow D, McCarron P, Woolfson A, Donnelly R. Innovative strategies for enhancing topical and transdermal drug delivery. Open Drug Deliv J. 2007; 1: 36-59.
5. Barry B, Williams A. Permeation enhancement through skin. In: Swarbrick J, Boylan JC, editors. Encyclopedia of Pharmaceutical Technology, ed., New York: Marcel Dekker; 1995. vol. 11, Ed: 1, p. 449-93.
6. Gasperlin M, Gosenca M. Main approaches for delivering antioxidant vitamins through the skin to prevent skin ageing. Expert Opin Drug Deliv. 2011; 8(7): 905-19.
7. Saupe A, Wissing S, Lenk A, Schmidt C, Muller R. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC)-structural investigations on two different carrier systems. Biomed Mater Eng. 2005; 15(5): 393-402.
8. Schafer-Korting M, Mehnert W, Korting H. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev. 2007; 59(6): 427-43.
9. Souto EB, Muller RH. Cosmetic features and applications of lipid nanoparticles (SLN, NLC). Int J Cosmet Sci. 2008; 30(3): 157-65.
10. Müller R, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur J Pharm Biopharm. 2000; 50(1): 161-77.
11. Honeywell-Nguyen P, Bouwstra J. Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today Technol. 2005; 2(1): 67-74.
12. Souto E, Almeida A, Müller R. Lipid nanoparticles (SLN®, NLC®) for cutaneous drug delivery: structure, protection and skin effects. J Biomed Nanotechnol. 2007; 3(4): 317-31.
13. Kreilgaard M. Assessment of cutaneous drug delivery using microdialysis. Adv Drug Deliv Rev. 2002; 54(Suppl 1): S99-121.
14. Rakshit AK, Moulik SP. Physicochemistry of w/o microemulsions: formation, stability and droplet clustering. In: Fanun M, editor. Microemulsions: properties and applications. Surfactant science series vol. 144. Boca Raton: CRC Press; 2008. p. 17-58.
15. Heuschkel S, Goebel A, Neubert R. Microemulsions-modern colloidal carrier for dermal and transdermal drug delivery. J Pharm Sci. 2008; 97(2): 603-31.
16. Schroeter A, Engelbrecht T, Neubert R, Goebel A. New nanosized technologies for dermal and transdermal drug delivery. A review. J Biomed Nanotechnol. 2010; 6(5): 511-28.
17. Kemken J, Ziegler A, Muller B. Influence of supersaturation on the pharmacodynamic effect of bupranolol after dermal administration using microemulsions as vehicle. Pharm Res. 1992; 9(4): 554-8.
18. Chen H, Chang X, Weng T, Zhao X, Gao Z, Yang Y, Xu H, Yang X. A study of microemulsion systems for transdermal delivery of triptolide. J Control Release. 2004; 98(3): 427-36.
19. Hua L, Weisan P, Jiayu L, Ying Z. Preparation, evaluation, and NMR characterization of vinpocetine microemulsion for transdermal delivery. Drug Dev Ind Pharm. 2004; 30(6): 657-66.
20. Effendy I, Maibach HI. Surfactants and experimental irritant contact dermatitis. Contact Dermatitis. 1995; 33(4): 217-25.
21. Rieger MM, Rhein LD, editors. Surfactants in cosmetics. 2nd edition, revised and expanded. Surfactant science series, vol. 68. New York: Marcel Dekker; 1997.
22. Tenjarla S. Microemulsions: an overview and pharmaceutical applications. Crit Rev Ther Drug Carrier Syst. 1999; 16(5): 461-521.
23. Gupta R, Jain S, Varshney M. AOT water-in-oil microemulsions as a penetration enhancer in transdermal drug delivery of 5-fluorouracil. Colloids Surf B Biointerfaces. 2005; 41(1): 25-32.
24. Liu H, Wang Y, Lang Y, Yao H, Dong Y, Li S. Bicontinuous cyclosporin a loaded water-AOT/Tween 85-isopropylmyristate microemulsion: structural characterization and dermal pharmacokinetics in vivo. J Pharm Sci. 2009; 98(3): 1167-76.
25. Trommer H, Neubert R. Overcoming the stratum corneum: the modulation of skin penetration. A review. Skin Pharmacol Physiol. 2006; 19(2): 106-21.
26. Okamoto H, Sakai T, Danjo K. Effect of sucrose fatty acid esters on transdermal permeation of lidocaine and ketoprofen. Biol Pharm Bull. 2005; 28(9): 1689-94.
27. Pakpayat N, Nielloud F, Fortune R, Tourne-Peteilh C, Villarreal A, Grillo I, Bataille B. Formulation of ascorbic acid microemulsions with alkyl polyglycosides. Eur J Pharm Biopharm. 2009; 72(2): 444-52.
28. El Meshad AN, Tadros MI. Transdermal delivery of an anti-cancer drug via w/o emulsions based on alkyl polyglycosides and lecithin: Design, characterization, and in vivo evaluation of the possible irritation potential in rats. AAPS PharmSciTech 2011; 12(1): 1-9.
29. Manconi M, Sinico C, Caddeo C, Vila AO, Valenti D, Fadda AM. Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin. Int J Pharm. 2011; 412(1-2): 37-46.
30. Chessa M, Caddeo C, Valenti D, Manconi M, Sinico C, Fadda A. Effect of penetration enhancer containing vesicles on the percutaneous delivery of quercetin through new born pig skin. Pharmaceutics. 2011; 3(3): 497-509.
31. Mura S, Manconi M, Sinico C, Valenti D, Fadda A. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. Int J Pharm. 2009; 380(1-2): 72-9.
32. Williams AC, Barry BW. Chemical permeation enhancement. In: Touitou E, Barry BW, editors. Enhancement in drug delivery. Boca Raton: CRC Press; 2006.
33. Kirjavainen M, Mönkkönen J, Saukkosaari M, Valjakka-Koskela R, Kiesvaara J, Urtti A. Phospholipids affect stratum corneum lipid bilayer fluidity and drug partitioning into the bilayers. J Control Release. 1999; 58(2): 207-14.
34. Rhee Y, Choi J, Park E, Chi S. Transdermal delivery of ketoprofen using microemulsions. Int J Pharm. 2001; 228(1-2): 161-70.
35. Zhang J, Michniak-Kohn B. Investigation of microemulsion microstructures and their relationship to transdermal permeation of model drugs: ketoprofen, lidocaine, and caffeine. Int J Pharm. 2011; 421(1): 34-44.
36. Changez M, Varshney M, Chander J, Dinda AK. Effect of the composition of lecithin/n-propanol/ isopropyl myristate/water microemulsions on barrier properties of mice skin for transdermal permeation of tetracaine hydrochloride: in vitro. Colloids Surf B Biointerfaces. 2006; 50(1): 18-25.
37. Djordjevic L, Primorac M, Stupar M. In vitro release of diclofenac diethylamine from caprylocaproyl macrogolglycerides based microemulsions. Int J Pharm. 2005; 296(1-2): 73-9.
38. Sintov A, Shapiro L. New microemulsion vehicle facilitates percutaneous penetration in vitro and cutaneous drug bioavailability in vivo. J Control Release. 2004; 95(2): 173-83.
39. Osborne DW, Ward AJ, O'Neill KJ. Microemulsions as topical drug delivery vehicles: in-vitro transdermal studies of a model hydrophilic drug. J Pharm Pharmacol. 1991; 43(6): 450-4.
40. Mou D, Chen H, Du D, Mao C, Wan J, Xu H, Yang X. Hydrogel-thickened nanoemulsion system for topical delivery of lipophilic drugs. Int J Pharm. 2008; 353(1-2): 270-6.
41. Zhu W, Yu A, Wang W, Dong R, Wu J, Zhai G. Formulation design of microemulsion for dermal delivery of penciclovir. Int J Pharm. 2008; 360(1-2): 184-90.
42. Lusiana, Müller-Goymann C. Preparation, characterization, and in vitro permeation study of terbinafine HCl in poloxamer 407-based thermogelling formulation for topical application. AAPS PharmSciTech. 2011; 12(2): 496-506.
43. Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2004; 56(5): 603-18.
44. Chen L, Tan F, Wang J, Liu F. Microemulsion: a novel transdermal delivery system to facilitate skin penetration of indomethacin. Pharmazie. 2012; 67(4): 319-23.
45. Peltola S, Saarinen-Savolainen P, Kiesvaara J, Suhonen TM, Urtti A. Microemulsions for topical delivery of estradiol. Int J Pharm. 2003; 254(2): 99-107.
46. Megrab N, Williams A, Barry B. Oestradiol permeation across human skin, silastic and snake skin membranes: the effects of ethanol/water co-solvent systems. Int J Pharm. 1995; 116(1): 101-12.
47. Kumar A, Agarwal S, Ahuja A, Ali J, Choudhry R, Baboota S. Preparation, characterization, and in vitro antimicrobial assessment of nanocarrier based formulation of nadifloxacin for acne treatment. Pharmazie. 2011; 66(2): 111-4.
48. Kweon J, Chi S, Park E. Transdermal delivery of diclofenac using microemulsions. Arch Pharm Res. 2004; 27(3): 351-6.
49. Lee P, Langer R, Shastri V. Novel microemulsion enhancer formulation for simultaneous transdermal delivery of hydrophilic and hydrophobic drugs. Pharm Res. 2003; 20(2): 264-9.
50. Chudasama A, Patel V, Nivsarkar M, Vasu K, Shishoo C. Investigation of microemulsion system for transdermal delivery of itraconazole. J Adv Pharm Technol Res. 2011; 2(1): 30-8.
51. Dalvi U, Zatz J. Effect of skin binding on percutaneous transport of benzocaine from aqueous suspensions and solutions. J Pharm Sci. 1982; 71(7): 824-6.
52. Lopez A, Llinares F, Cortell C, Herraez M. Comparative enhancer effects of Span20 with Tween20 and azone on the in vitro percutaneous penetration of compounds with different lipophilicities. Int J Pharm. 2000; 202(1-2): 133-40.
53. Hwang C, Danti A. Percutaneous absorption of flufenamic acid in rabbits: effect of dimethyl sulfoxide and various nonionic surface-active agents. J Pharm Sci. 1983; 72(8): 857-60.
54. Wu H, Ramachandran C, Weiner ND, Roessler BJ. Topical transport of hydrophilic compounds using water-in-oil nanoemulsions. Int J Pharm. 2001; 220(1-2): 63-75.
55. Vicentini FT, Simi TR, Del Ciampo JO, Wolga NO, Pitol DL, Iyomasa MM, Bentley MV, Fonseca MJ. Quercetin in w/o microemulsion: in vitro and in vivo skin penetration and efficacy against UVBinduced skin damages evaluated in vivo. Eur J Pharm Biopharm. 2008; 69(3): 948-57.
56. Ganem-Quintanar A, Lafforgue C, Falson-Rieg F, Buri P. Evaluation of the transepidermal permeation of diethylene glycol monoethyl ether and skin water loss. Int J Pharm. 1997; 147(2): 165-71.
57. Watkinson A, Hadgraft J, Bye A. Aspects of the transdermal delivery of prostaglandins. Int J Pharm. 1991; 74(2-3): 229-36.
58. Escobar-Chavez JJ, Quintanar-Guerrero D, Ganem-Quintanar A. In vivo skin permeation of sodium naproxen formulated in pluronic f-127 gels: effect of azone and transcutol. Drug Dev Ind Pharm. 2005; 31(4-5): 447-54.
59. Harrison J, Watkinson A, Green D, Hadgraft J, Brain K. The relative effect of Azone and Transcutol on permeant diffusivity and solubility in human stratum corneum. Pharm Res. 1996; 13(4): 542-6.
60. Censi R, Martena V, Hoti E, Malaj L, Di Martino P. Permeation and skin retention of quercetin from microemulsions containing Transcutol® P. Drug Dev Ind Pharm. 2012; 38(9): 1128-33.
61. Escribano E, Calpena A, Queralt J, Obach R, Domenech J. Assessment of diclofenac permeation with different formulations: anti-inflammatory study of a selected formula. Eur J Pharm Sci. 2003; 19(4): 203-10.
62. Hua L, Weisan P, Jiayu L, Hongfei L. Preparation and evaluation of microemulsion of vinpocetine for transdermal delivery. Pharmazie. 2004; 59(4): 274-8.
63. Shakeel F, Baboota S, Ahuja A, Ali J, Aqil M, Shafiq S. Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS PharmSciTech. 2007; 8(4): E104.
64. Panapisal V, Charoensri S, Tantituvanont A. Formulation of microemulsion systems for dermal delivery of silymarin. AAPS PharmSciTech. 2012; 13(2): 389-99.
65. Ali J, Akhtar N, Sultana Y, Baboota S, Ahuja A. Antipsoriatic microemulsion gel formulations for topical drug delivery of babchi oil (Psoralea corylifolia). Methods Find Exp Clin Pharmacol. 2008; 30(4): 277-85. 70.
66. Fini A, Bergamante V, Ceschel GC, Ronchi C, De Moraes CA. Control of transdermal permeation of hydrocortisone acetate from hydrophilic and lipophilic formulations. AAPS PharmSciTech. 2008; 9(3): 762-8.
67. Barot BS, Parejiya PB, Patel HK, Gohel MC, Shelat PK. Microemulsion-based gel of terbinafine for the treatment of onychomycosis: optimization of formulation using d-optimal design. AAPS PharmSciTech. 2012; 13(1): 184-92.
68. Hathout R, Woodman T, Mansour S, Mortada N, Geneidi A, Guy R. Microemulsion formulations for the transdermal delivery of testosterone. Eur J Pharm Sci. 2010; 40(3): 188-96.
69. Pappinen S, Urtti A. Microemulsions in topical drug delivery. In: Smith EW, Maibach HI, editors. Percutaneous penetration enhancers. 2nd edition. Boca Raton: Taylor and Francis; 2006. Ed: 2, p. 109-116.
70. Kogan A, Garti N. Microemulsions as transdermal drug delivery vehicles. Adv Colloid Interface Sci. 2006; 123-126: 369-85.
71. Hathout R, Mansour S, Geneidi A, Mortada N. Visualization, dermatopharmacokinetic analysis and monitoring the conformational effects of a microemulsion formulation in the skin stratum corneum. J Colloid Interface Sci. 2011; 354(1): 124-30.
72. Rosen MK, Kunjappu JT. Characteristic features of the surfactants. In: Rosen MK, Kunjappu JT. Surfactants and interfacial phenomena. 4th edition. New Jersey: John Wiley & Sons; 2012. p. 1-38.
73. Puranajoti P, Patil T, Sheth P, Bommareddy G, Egbaria D. Design and development of topical microemulsion for poorly water-soluble antifungal agents. J Appl Res. 2002; 2(3): 10-9.
74. Derle D, Sagar B, Sagar P. Microemulsion as a vehicle for transdermal permeation of nimesulide. Indian J Pharm Sci. 2006; 68(5): 622-5.
75. Chandra A, Sharma P, Irchhiaya R. Microemulsion-based hydrogel formulation for transdermal delivery of dexamethasone. Asian J Pharm. 2009; 3(1): 30-6.
76. Valenta C, Schultz K. Influence of carrageenan on the rheology and skin permeation of microemulsion formulations. J Control Release. 2004; 95(2): 257-65.
77. Kantarci G, Ozguney I, Karasulu H, Arzik S, Guneri T. Comparison of different water/oil microemulsions containing diclofenac sodium: preparation, characterization, release rate, and skin irritation studies. AAPS PharmSciTech. 2007; 8(4): E91.
78. Fang JY, Leu YL, Chang CC, Lin CH, Tsai YH. Lipid nano/submicron emulsions as vehicles for topical flurbiprofen delivery. Drug Deliv. 2004; 11(2): 97-105.
79. Hosmer J, Reed R, Bentley M, Nornoo A, Lopes L. Microemulsions containing medium-chain glycerides as transdermal delivery systems for hydrophilic and hydrophobic drugs. AAPS PharmSci-Tech. 2009; 10(2): 589-96.
80. Marku D, Wahlgren M, Rayner M, Sjoo M, Timgren A. Characterization of starch Pickering emulsions for potential applications in topical formulations. Int J Pharm. 2012; 428(1-2): 1-7.
81. Rhee Y, Choi J, Park E, Chi S. Transdermal delivery of ketoprofen using microemulsions. Int J Pharm. 2001; 228(1-2): 161-70.
82. Park E, Cui Y, Yun B, Ko I, Chi S. Transdermal delivery of piroxicam using microemulsions. Arch Pharm Res. 2005; 28(2): 243-8.
83. Suppasansatorn P, Nimmannit U, Conway B, Du L, Wang Y. Microemulsions as topical delivery vehicles for the anti-melanoma prodrug, temozolomide hexyl ester (TMZA-HE). J Pharm Pharmacol. 2007; 59(6): 787-94.
84. Malakar J, Sen SO, Nayak AK, Sen KK. Development and evaluation of microemulsions for transdermal delivery of insulin. ISRN Pharm. 2011; 2011: 1-14.
85. Zhao X, Liu JP, Zhang X, Li Y. Enhancement of transdermal delivery of theophylline using microemulsion vehicle. Int J Pharm. 2006; 327(1-2): 58-64.
86. Al Abood R, Talegaonkar S, Tariq M, Ahmad F. Microemulsion as a tool for the transdermal delivery of ondansetron for the treatment of chemotherapy induced nausea and vomiting. Colloids Surf B Biointerfaces. 2013; 101: 143-51.
87. Gao S, Singh J. Effect of oleic acid/ethanol and oleic acid/propylene glycol on the in vitro percutaneous absorption of 5-fluorouracil and tamoxifen and the macroscopic barrier property of porcine epidermis. Int J Pharm. 1998; 165(1): 45-55.
88. Hathout R, Elshafeey A. Development and characterization of colloidal soft nano-carriers for transdermal delivery and bioavailability enhancement of an angiotensin ii receptor blocker. Eur J Pharm Biopharm. 2012; 82(2): 230-40.
89. Kumar S, Talegaonkar S, Negi L, Khan Z. Design and development of ciclopirox topical nanoemulsion gel for the treatment of subungual onychomycosis. Indian J Pharm Educ Res. 2012; 46(4): 303-11.
90. Sabale V, Vora S. Formulation and evaluation of microemulsion-based hydrogel for topical delivery. Int J Pharm Investig. 2012; 2(3): 140-9.
91. Schroeter A, Engelbrecht T, Neubert R, Goebel A. New nanosized technologies for dermal and transdermal drug delivery. A review. J Biomed Nanotechnol. 2010; 6(5): 511-28.
92. Yang JH, Kim YI, Kim KM. Preparation and evaluation of aceclofenac microemulsion for transdermal delivery system. Arch Pharm Res. 2002; 25(4): 534-40.
93. Liu C, Huang H. Antimicrobial activity of curcumin-loaded myristic acid microemulsions against staphylococcus epidermidis. Chem Pharm Bull (Tokyo). 2012; 60(9): 1118-24.
94. Patel M, Patel R, Parikh J, Solanki A, Patel B. Effect of formulation components on the in vitro permeation of microemulsion drug delivery system of fluconazole. AAPS PharmSciTech. 2009; 10(3): 917-23.
95. Osborne D, Ward A, O'Neill K. Microemulsions as topical drug delivery vehicles: pn-vitro transdermal studies of a model hydrophilic drug. J Pharm Pharmacol. 1991; 43(6): 451-4.
96. Osborne D, Ward A, O'Neill K. Microemulsions as topical drug delivery vehicles. I. Characterization of a model system. Drug Dev Ind Pharm. 1998; 14(9): 1203-19.
97. Trotta M, Pattarino F, Gasco M. Influence of counter ions on the skin permeation of methotrexate from water-oil microemulsions. Pharm Acta Helv. 1996; 71(2): 135-40.
98. Peira E, Scolari P, Gasco M. Transdermal permeation of apomorphine through hairless mouse skin from microemulsions. Int J Pharm. 2001; 226(1-2): 47-51.
99. Peira E, Carlotti M, Trotta C, Cavalli R, Trotta M. Positively charged microemulsions for topical application. Int J Pharm. 2008; 346(1-2): 119-23.
100. Lopes L, Van De Wall H, Li H, Venugopal V, Li H, Naydin S, Hosmer J, Levendusky M, Zheng H, Bentley M, Levin R, Hass M. Topical delivery of lycopene using microemulsions: enhanced skin penetration and tissue antioxidant activity. J Pharm Sci. 2010; 99(3): 1346-57.
101. Subramanian N, Ghosal S, Moulik S. Topical delivery of celecoxib using microemulsion. Acta Pol Pharm. 2004; 61(5): 335-41.
102. Biruss B, Valenta C. The advantage of polymer addition to a non-ionic oil in water microemulsion for the dermal delivery of progesterone. Int J Pharm. 2008; 349(1-2): 269-73.
103. Schwarz J, Weisspapir M, Friedman D. Enhanced transdermal delivery of diazepam by submicron emulsion (SME) creams. Pharm Res. 1995; 12(5): 687-92.
104. Piemi M, Korner D, Benita S, Marty J. Positively and negatively charged submicron emulsions for enhanced topical delivery of antifungal drugs. J Control Release. 1999; 58(2): 177-87.
105. Paolino D, Ventura C, Nistico S, Puglisi G, Fresta M. Lecithin microemulsions for the topical administration of ketoprofen: Percutaneous adsorption through human skin and in vivo human skin tolerability. Int J Pharm. 2002; 244(1-2): 21-31.
106. Alvarez-Figueroa M, Delgado-Charro M, Blanco-Mendez J. Passive and iontophoretic transdermal penetration of methotrexate. Int J Pharm. 2001; 212(1): 101-7.
107. Delgado-Charro M, Iglesias-Vilas G, Blanco-Méndez J, López-Quintela M, Marty J, Guy R. Delivery of a hydrophilic solute through the skin from novel microemulsion systems. Eur J Pharm Biopharm. 1997; 43(1): 37-42.
108. Araujo L, Thomazine J, Lopez R. Development of microemulsions to topically deliver 5-aminolevulinic acid in photodynamic therapy. Eur J Pharm Biopharm. 2010; 75(1): 48-55.
109. Zhang YT, Zhao JH, Zhang SJ, Zhong YZ, Wang Z, Liu Y, Shi F, Feng NP. Enhanced transdermal delivery of evodiamine and rutaecarpine using microemulsion. Int J Nanomedicine. 2011; 2011(6): 2469-82.
110. Subramanian N, Ghosal S, Moulik S. Enhanced in vitro percutaneous absorption and in vivo antiinflammatory effect of a selective cyclooxygenase inhibitor using microemulsion. Drug Dev Ind Pharm. 2005; 31(4-5): 405-16.
111. Mei Z, Chen H, Weng T, Yang Y, Yang X. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur J Pharm Biopharm. 2003; 56(2): 189-96.
112. Yuan Y, Li SM, Mo FK, Zhong DF. Investigation of microemulsion system for transdermal delivery of meloxicam. Int J Pharm. 2006; 321(1-2): 117-23.
113. Wilisch I, Müller-Goymann C. Correlation of colloidal microstructure, drug release and permeation through excised human skin. Int J Pharm. 1993; 96(1-3): 79-84.
114. Rozman B, Gasperlin M, Tinois-Tessoneaud E, Pirot F, Falson F. Simultaneous absorption of vitamins C and E from topical microemulsions using reconstructed human epidermis as a skin model. Eur J Pharm Biopharm. 2009; 72(1): 69-75.
115. Tashtoush B, Bennamani A, Al-Taani B. Preparation and characterization of microemulsion formulations of nicotinic acid and its prodrugs for transdermal delivery. Pharm Dev Technol. 2013; 18(4): 834-43.
116. Kitagawa S, Tanaka Y, Tanaka M, Endo K, Yoshii A. Enhanced skin delivery of quercetin by microemulsion. J Pharm Pharmacol. 2009; 61(7): 855-60.
117. Tsai Y, Lee K, Huang Y, Huang C, Wu P. In vitro permeation and in vivo whitening effect of topical hesperetin microemulsion delivery system. Int J Pharm. 2010; 388(1-2): 257-62.
118. Raza K, Negi P, Takyar S, Shukla A, Amarji B, Katare O. Novel dithranol phospholipid microemulsion for topical application: development, characterization and percutaneous absorption studies. J Microencapsul. 2011; 28(3): 190-9.
119. Tsai Y, Chang J, Chang J, Huang C, Huang Y, Wu P. The effect of component of microemulsions on transdermal delivery of buspirone hydrochloride. J Pharm Sci. 2011; 100(6): 2358-65.
120. Schmalfusz U, Neubert R, Wohlrab W. Modification of drug penetration into human skin using microemulsions. J Control Release. 1997; 46(3): 279-85.
121. Chen H, Mou D, Du D, Chang X, Zhu D, Liu J, Xu H, Yang X. Hydrogel-thickened microemulsion for topical administration of drug molecule at an extremely low concentration. Int J Pharm. 2007; 341(1-2): 78-84.
122. Wu P, Lin Y, Chang J, Huang Y, Tsai Y. The effect of component of microemulsion for transdermal delivery of nicardipine hydrochloride. Drug Dev Ind Pharm. 2010; 36(12): 1398-403.
123. Kitagawa S, Yoshii K, Morita S, Teraoka R. Efficient topical delivery of chlorogenic acid by an oil-in-water microemulsion to protect skin against UV-induced damage. Chem Pharm Bull (Tokyo). 2011; 59(6): 793-6.
124. Ambade K, Jadhav S, Gambhire M, Kurmi S, Kadam V, Jadhav K. Formulation and evaluation of flurbiprofen microemulsion. Curr Drug Deliv. 2008; 5(1): 32-41.
125. Ustundag O, Apaydin S, Karabay Yavasoglu N, Yavasoglu A, Karasulu H. Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations. Int J Pharm. 2011; 416(1): 136-44.
126. Tavano L, Alfano P, Muzzalupo R, de Cindio B. Niosomes vs microemulsions: new carriers for topical delivery of capsaicin. Colloids Surf B Biointerfaces. 2011; 87(2): 333-9.
127. Ktistis G, Niopas I. A study on the in-vitro percutaneous absorption of propranolol from disperse systems. J Pharm Pharmacol. 1998; 50(4): 413-8.
128. Luo M, Shen Q, Chen J. Transdermal delivery of paeonol using cubic gel and microemulsion gel. Int J Nanomedicine. 2011; 6: 1603-10.
129. Cao F, Ou Yang W, Wang Y, Yue P, Li S. A combination of a microemulsion and a phospholipid complex for topical delivery of oxymatrine. Arch Pharm Res. 2011; 34(4): 551-62.
130. Baroli B, López-Quintela M, Delgado-Charro M, Fadda A, Mendez J. Microemulsions for topical delivery of 8-methoxsalen. J Control Release. 2000; 69(1): 209-18.
131. Alvarez-Figueroa M, Blanco-Mendez J. Transdermal delivery of methotrexate: iontophoretic delivery from hydrogels and passive delivery from microemulsions. Int J Pharm. 2001; 215(1-2): 57-65.
132. Shishu, Rajan S, Kamalpreet. Development of novel microemulsion-based topical formulations of acyclovir for the treatment of cutaneous herpetic infections. AAPS PharmSciTech. 2009; 10(2): 559-65.
133. Yuan J, Ansari M, Samaan M, Acosta E. Linker-based lecithin microemulsions for transdermal delivery of lidocaine. Int J Pharm. 2008; 349(1-2): 130-43.
134. Sintov A, Botner S. Transdermal drug delivery using microemulsion and aqueous systems: Influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems. Int J Pharm. 2006; 311(1-2): 55-62.
135. Elshafeey A, Kamel A, Fathallah M. Utility of nanosized microemulsion for transdermal delivery of tolterodine tartrate: ex-vivo permeation and in-vivo pharmacokinetic studies. Pharm Res 2009; 26(11): 2446-53.
136. Lehmann L, Keipert S, Gloor M. Effects of microemulsions on the stratum corneum and hydrocortisone penetration. Eur J Pharm Biopharm. 2001; 52(2): 129-36.
137. Changez M, Chander J, Dinda A. Transdermal permeation of tetracaine hydrochloride by lecithin microemulsion: in vivo. Colloids Surf B Biointerfaces 2006; 48(1): 58-66.
138. Podlogar F, Bester Rogac M, Gasperlin M. The effect of internal structure of selected water-Tween 40-imwitor 308-IPM microemulsions on ketoprofene release. Int J Pharm. 2005; 302(1-2): 68-77.
139. Hashem F, Shaker D, Ghorab M, Nasr M, Ismail A. Formulation, characterization, and clinical evaluation of microemulsion containing clotrimazole for topical delivery. AAPS PharmSciTech. 2011; 12(3): 879-86.
140. Holler S, Valenta C. Effect of selected fluorinated drugs in a "ringing" gel on rheological behaviour and skin permeation. Eur J Pharm Biopharm. 2007; 66(1): 120-6.
141. Kemken J, Ziegler A, Müller B. Investigations into the pharmacodynamic effects of dermally administered microemulsions containing beta-blockers. J Pharm Pharmacol. 1991; 43(10): 679-84.
142. Getie M, Wohlrab J, Neubert R. Dermal delivery of desmopressin acetate using colloidal carrier systems. J Pharm Pharmacol. 2005; 57(4): 423-7.
143. Junyaprasert V, Boonme P, Songkro S, Krauel K, Rades T. Transdermal delivery of hydrophobic and hydrophilic local anesthetics from o/w and w/o Brij 97-based microemulsions. J Pharm Pharm Sci. 2007; 10(3): 288-98.
144. Dreher F, Walde P, Walther P, Wehrli E. Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport. J Control Release. 1997; 45(2): 131-40.
145. Neubert R, Schmalfuss U, Wolf R, Wohlrab W. Microemulsions as colloidal vehicle systems for dermal drug delivery. Part V: microemulsions without and with glycolipid as penetration enhancer. J Pharm Sci. 2005; 94(4): 821-7.
146. Bonina F, Montenegro L, Scrofani N, Esposito E, Cortesi R, Menegatti E, Nastruzzi C. Effects of phospholipid based formulations on in vitro and in vivo percutaneous absorption of methyl nicotinate. J Control Release. 1995; 34(1): 53-63.
147. Kreilgaard M, Pedersen E, Jaroszewski J. NMR characterisation and transdermal drug delivery potential of microemulsion systems. J Control Release. 2000; 69(3): 421-33.
148. Escribano E, Calpena A, Queralt J, Obach R, Doménech J. Assessment of diclofenac permeation with different formulations: anti-inflammatory study of a selected formula. Eur J Pharm Sci. 2003; 19(4): 203-10.
149. Loftsson T, Petersen D, Le Goffic F, Olafsson J. Unsaturated glycerol monoethers as novel skin penetration enhancers. Pharmazie. 1997; 52(6): 463-5.
150. Bentley M, Kedor E, Vianna R, Collett J. The influence of lecithin and urea on the in vitro permeation of hydrocortisone acetate through skin from hairless mouse. Int J Pharm. 1997; 146(2): 255-62.
151. Bonina F, Montenegro L. Effects of some non-toxic penetration enhancers on in vitro heparin skin permeation from gel vehicles. Int J Pharm. 1994; 111(2): 191-6.
152. Barry B. Action of skin penetration enhancers-the lipid protein partitioning theory. Int J Cosmet Sci. 1988; 10(6): 281-93.
153. Mahjour M, Mauser B, Rashidbaigi Z, Fawzi MB. Effect of egg yolk lecithins and commercial soybean lecithins on in vitro skin permeation of drugs. J Control Release. 1990; 14(3): 243-52.
154. Saija A, Tomaino A, Trombetta D, Giacchi M, De Pasquale A, Bonina F. Influence of different penetration enhancers on in vitro skin permeation and in vivo photoprotective effect of flavonoids. Int J Pharm. 1998; 175(1): 85-94.
155. Yokomizo Y, Sagitani H. Effects of phospholipids on the in vitro percutaneous penetration of prednisolone and analysis of mechanism by using attenuated total reflectance-Fourier transform infrared spectroscopy. J Pharm Sci. 1996; 85(11): 1220-6.
156. Barry BW. Lipid-protein-partitioning theory of skin penetration enhancement. J Control Release. 1991; 15(3): 237-48.
157. Valenta C, Wanka M, Heidlas J. Evaluation of novel soya-lecithin formulations for dermal use containing ketoprofen as a model drug. J Control Release. 2000; 63(1-2): 165-73.
158. Kantarci G, Ozguney I, Karasulu H, Arzik S, Guneri T. Comparison of different water/oil microemulsions containing diclofenac sodium: preparation, characterization, release rate, and skin irritation studies. AAPS PharmSciTech. 2007; 8(7): E91.
159. Mittal A, Sara U, Ali A, Aqil M. Status of fatty acids as skin penetration enhancers-a review. Curr Drug Deliv. 2009; 6(3): 274-9.
160. Babu RJ, Singh M, Kanikkannan N, editors. Fatty alcohols and fatty acids. In: Smith EW, Maibach HI. Percutaneous penetration enhancers. 2nd edition. Boca Raton, FL: CRC Press; 2005. p. 137-58.
161. Golden G, McKie J, Potts R. Role of stratum corneum lipid fluidity in transdermal drug flux. J Pharm Sci. 1987; 76(1): 25-8.
162. Moghadam S, Saliaj E, Wettig S, Dong C, Ivanova M, Huzil J, Foldvari M. Effect of chemical permeation enhancers on stratum corneum barrier lipid organizational structure and interferon alpha permeability. Mol Pharm. 2013; 10(6): 2248-60.
163. Trommer H, Neubert RH. Overcoming the stratum corneum: the modulation of skin penetration. A review. Skin Pharmacol Physiol. 2006; 19(2): 106-21.
164. Benson HA. Transdermal drug delivery: penetration enhancement techniques. Curr Drug Deliv. 2005; 2(1): 23-33.
165. Goebel A, Schmaus G, Neubert R, Wohlrab J. Dermal peptide delivery using enhancer molecules and colloidal carrier systems-part I: carnosine. Skin Pharmacol Physiol. 2012; 25(6): 281-7.
166. Trotta M, Pattarino F, Gasco MR. Influence of counter ions on the skin permeation of methotrexate from water-oil microemulsions. Pharm Acta Helv. 1996; 71(2): 135-40.
167. Peira E, Scolari P, Gasco M. Transdermal permeation of apomorphine through hairless mouse skin from microemulsions. Int J Pharm. 2001; 226(1-2): 47-51.
168. Amar-Yuli I, Aserin A, Garti N. Interfacial reactivity at liquid crystal interfaces. In: Garti N, Amar-Yuli I, editors. Nanotechnologies for solubilization and delivery in foods, and cosmetics pharmaceuticals. Lancaster, PA: DEStech Publications Inc.; 2011. p. 209-26.
169. Quan D, Deshpanday NA, Venkateshwaran S, Ebert CD, inventors; Theratech, Inc., assignee. Triacetin as a penetration enhancer for transdermal delivery of a basic drug. United States patent US 5834010. 1998 Nov 10.
170. Heiber E, Patel C, Venkateshwaran S, inventors; Theratech, Inc., assignee. The use of glycerin in moderating transdermal drug delivery. European patent EPO 0644746-A1. 29 March 1995.
171. Junyaprasert V, Boonme P, Songkro S, Krauel K, Rades T. Transdermal delivery of hydrophobic and hydrophilic local anesthetics from o/w and w/o Brij 97-based microemulsions. J Pharm Sci. 2007; 10(3): 288-98.
172. Neubert R, Schmalfuss U, Wolf R, Wohlrab W. Microemulsions as colloidal vehicle systems for dermal drug delivery. Part V: microemulsions without and with glycolipid as penetration enhancer. J Pharm Sci. 2005; 94(4): 821-7.
173. Azeem A, Rizwan M, Ahmad F, Iqbal Z, Khar R, Agil M, Talegaonkar S. Nanoemulsion components screening and selection: atechnical note. AAPS PharmSciTech. 2009; 10(1): 69-76.
174. Constantinides P. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res. 1995; 12(11): 1561-72.
175. Kimura M, Miwa S, Kazuyo M, Tomomi S, Hiroshi H, Hitoshi T, Teruyoshi M. Relationship between molecular structure and emulsification properties of edible oils. Biosci Biotech Biochem. 1994; 58(7): 1258-61.
176. Hauss D, Fogal S, Ficorilli J, Price C, Roy T, Jayaraj A, Keirns J. Lipid based delivery systems for improving bioavailability and lymphatic transport of a poorly water soluble lt b4 inhibitor. J Pharm Sci. 1998; 87(2): 164-9.